BRPI0606593A2 - mistura de substáncias - Google Patents

mistura de substáncias

Info

Publication number
BRPI0606593A2
BRPI0606593A2 BRPI0606593-7A BRPI0606593A BRPI0606593A2 BR PI0606593 A2 BRPI0606593 A2 BR PI0606593A2 BR PI0606593 A BRPI0606593 A BR PI0606593A BR PI0606593 A2 BRPI0606593 A2 BR PI0606593A2
Authority
BR
Brazil
Prior art keywords
substances
mixture
well
medicament
chlorine compound
Prior art date
Application number
BRPI0606593-7A
Other languages
English (en)
Inventor
Andreas Neher
Waldemar Gottardi
Markus Nagl
Bruno Pregenzer
Alfred Konzett
Original Assignee
Bruno Pregenzer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruno Pregenzer filed Critical Bruno Pregenzer
Publication of BRPI0606593A2 publication Critical patent/BRPI0606593A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

MISTURA DE SUBSTáNCIAS. A presente invenção refere-se a uma mistura de substâncias contendo pelo menos um glicocorticóide, e pelo menos um composto N-cloro e/ou pelo menos um composto O-cloro, bem como um medicamento que contém a referida mistura de substâncias, bem como o uso e fabricação do referido medicamento para tratamento tópico de inflamações.
BRPI0606593-7A 2005-01-17 2006-01-12 mistura de substáncias BRPI0606593A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0006605A AT501376B1 (de) 2005-01-17 2005-01-17 Glucokortikoid-hältiges arzneimittel
PCT/AT2006/000011 WO2006074495A1 (de) 2005-01-17 2006-01-12 Stoffgemisch

Publications (1)

Publication Number Publication Date
BRPI0606593A2 true BRPI0606593A2 (pt) 2009-07-07

Family

ID=36121383

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606593-7A BRPI0606593A2 (pt) 2005-01-17 2006-01-12 mistura de substáncias

Country Status (11)

Country Link
US (1) US20090029956A1 (pt)
EP (1) EP1841435A1 (pt)
JP (1) JP2008526898A (pt)
CN (1) CN101102778A (pt)
AT (1) AT501376B1 (pt)
BR (1) BRPI0606593A2 (pt)
CA (1) CA2594101A1 (pt)
MX (1) MX2007008648A (pt)
RU (1) RU2398587C2 (pt)
WO (1) WO2006074495A1 (pt)
ZA (1) ZA200705779B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT508949B1 (de) * 2009-10-22 2011-09-15 Bruno Pregenzer Antimikrobielles, viruzides und fungizides gemisch
ES2907961T3 (es) 2016-06-09 2022-04-27 De Nora Holdings Us Inc Producción electrolítica de soluciones de cloramina orgánica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH540898A (de) * 1969-03-11 1973-08-31 Schering Ag Verfahren zur Herstellung neuer 21-Halogensteroide
YU54476A (en) * 1975-03-31 1982-05-31 Taisho Pharmaceutical Co Ltd Process for obtaining 17-ester 21-halo-pregnane
JPH01313423A (ja) * 1988-06-03 1989-12-18 Biogal Gyogyszergyar 耳炎用点耳薬の新規製薬組成物
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US20040116521A1 (en) * 2000-09-14 2004-06-17 Waldemar Gottardi Fungicidal agent containing n-chlorotaurine and use thereof
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye

Also Published As

Publication number Publication date
CN101102778A (zh) 2008-01-09
RU2398587C2 (ru) 2010-09-10
AT501376A1 (de) 2006-08-15
JP2008526898A (ja) 2008-07-24
MX2007008648A (es) 2007-09-14
AT501376B1 (de) 2010-11-15
EP1841435A1 (de) 2007-10-10
RU2007131286A (ru) 2009-02-27
US20090029956A1 (en) 2009-01-29
CA2594101A1 (en) 2006-07-20
WO2006074495A1 (de) 2006-07-20
ZA200705779B (en) 2009-01-28

Similar Documents

Publication Publication Date Title
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
HN2009000784A (es) Dihidropirazolonas sustituidas
CL2008002319A1 (es) Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
UY29086A1 (es) Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos.
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
BR112015011760A2 (pt) composto, uso do composto, e uso de uma composição farmacêutica
CL2007003202A1 (es) Compuestos derivados de espiroindolinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos de proliferacion celular.
GT201300121A (es) Derivados de 2,3-dihidroimidazo(1,2-c)quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
BRPI0712631B8 (pt) compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações
AR047928A1 (es) Derivados de tetrahidropiridoindol
CL2007002375A1 (es) Compuestos derivados de heteroarilo, inhibidores de citocina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del dolor, cancer, inflamacion, artritis, psoriasis, diabetes,
UY30364A1 (es) Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
UY31079A1 (es) Derivados de fenilaminobenceno sustituidos de utilidad para el tratamiento de trastornos y enfermedades hiperproliferativos asociados con actividad quinasa extracelular mediada por mitógenos
CL2008001721A1 (es) Compuestos derivados de 17-beta-ciano-18 alfa-homo-19-nor-androst-4-eno; que presentan actividad gestagena y antimineralcorticoide; composicion farmaceutica; y uso en el tratamiento de trastornos pre-peri-y posmenopausicos y trastornos premenstruales.
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
UY28662A1 (es) Agente endoparasiticida para administracion topica
ECSP088749A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
BRPI0915439B8 (pt) composição de gel tópica, bem como uso de um agente ativo para tratamento de ceratose actínica em combinação com um agente ceratoliticamente ativo para preparação da referida composição
CL2009000388A1 (es) Compuestos derivados de biciclos nitrogenados; proceso de preparacion; composicion farmaceutica; y su uso para tratar el dolor cronico que surge por inflamacion o neuropatia.
BR112012022243A8 (pt) Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico
CL2011002675A1 (es) Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende.
UY29767A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.